| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |